Managing Opioid Risks & Adverse Effects in a Politically Charged Environment

This activity is sponsored by educational grants from Salix Pharmaceuticals and Depomed, Inc.

Wednesday, September 6

Start Time

End Time

Gracia 1
Level 3

Program Description
Moderate-to-severe pain continues to be widely undertreated in outpatient settings, often due to fears of legal and regulatory sanctions, insurance barriers, and adverse outcomes from opioids. Despite the pain-relieving properties of opioid medications, the potential for abuse remains a concern among pri-mary care providers, pain management specialists, and other clinicians who manage patients with pain. The risk of contributing to an opioid use disorder or overdose is omnipresent.

When an opioid is used, clinicians must find safe and effective ways to manage adverse effects, such as opioid-induced constipation (OIC). As many as 80% of patients taking an opioid medication experience at least one adverse event, which diminishes overall satisfaction and limits a patient's ability to achieve adequate analgesia.

Engaging patients through an interdisciplinary approach can help patients effectively manage their pain. This includes ensuring patient adherence and making sure each patient understands how to properly take medication(s). Clinicians must be prepared to discuss potential side effects and ways to manage these events, and must address patient concerns regarding the use of opioids. Clinicians should also be familiar with new and emerging analgesic therapies, some of which tout an improved safety pro-file.

This educational initiative will address factors that prevent appropriate and safe opioid management of pain, and will explore the reduction of adverse effects associated with opioids. Increasing clinicians' awareness of evidence-based pain management can improve patient quality of life and satisfaction.

Learning Objectives

  • Recognize risks and benefits of analgesic therapies for chronic pain
  • Identify MOAs and safety and efficacy profiles of agents, particularly new and emerging agents that minimize side effects, to guide personalized pain-management plans
  • Discuss mitigation strategies and patient-centered approaches to overcome barriers associated with under-treatment of pain

Jeffrey A. Gudin, MD
Lynn R. Webster, MD

Pre-registration not required. Please arrive at least 15 minutes prior to start time.

Contact Name
Paula Larson

Contact Phone
(443) 539-4070

Contact email


Related Content